Core Laboratories (NYSE:CLB – Get Free Report) posted its earnings results on Wednesday. The oil and gas company reported $0.25 EPS for the quarter, beating the consensus estimate of $0.21 by $0.04, Briefing.com reports. Core Laboratories had a return on equity of 15.20% and a net margin of 5.44%. The firm had revenue of $134.40 million for the quarter, compared to analysts’ expectations of $134.16 million. During the same period last year, the firm earned $0.22 EPS. The firm’s revenue was up 7.2% compared to the same quarter last year. Core Laboratories updated its Q4 2024 guidance to 0.200-0.250 EPS and its Q4 guidance to $0.20-0.25 EPS.
Core Laboratories Trading Up 2.6 %
Shares of CLB stock traded up $0.50 during trading hours on Friday, reaching $19.44. 285,303 shares of the stock traded hands, compared to its average volume of 434,035. The company has a quick ratio of 1.68, a current ratio of 2.39 and a debt-to-equity ratio of 0.60. The firm has a market capitalization of $911.74 million, a PE ratio of 21.51, a PEG ratio of 1.08 and a beta of 2.36. Core Laboratories has a 1-year low of $13.82 and a 1-year high of $25.13. The business has a fifty day moving average price of $18.53 and a 200 day moving average price of $18.96.
Core Laboratories Dividend Announcement
The business also recently announced a quarterly dividend, which will be paid on Monday, November 25th. Stockholders of record on Monday, November 4th will be issued a dividend of $0.01 per share. This represents a $0.04 annualized dividend and a dividend yield of 0.21%. The ex-dividend date is Monday, November 4th. Core Laboratories’s dividend payout ratio is 4.55%.
Wall Street Analysts Forecast Growth
Read Our Latest Report on Core Laboratories
Core Laboratories Company Profile
Core Laboratories Inc provides reservoir description and production enhancement services and products to the oil and gas industry in the United States, and internationally. It operates through Reservoir Description and Production Enhancement segments. The Reservoir Description segment includes the characterization of petroleum reservoir rock and reservoir fluid samples to enhance production and improve recovery of crude oil and gas from its clients' reservoirs.
Featured Articles
- Five stocks we like better than Core Laboratories
- The Risks of Owning Bonds
- Texas Roadhouse Stock Steering for New Highs This Year
- What Are Growth Stocks and Investing in Them
- Monopar Therapeutics Skyrockets 400% on Licensing Deal
- 3 Fintech Stocks With Good 2021 Prospects
- Tractor Supply Stock Pulls Back: A Prime Buying Opportunity
Receive News & Ratings for Core Laboratories Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Core Laboratories and related companies with MarketBeat.com's FREE daily email newsletter.